FDA Vote Sets Stage for Gene Therapy's Future - MIT Technology Review
MIT Technology Review
FDA Vote Sets Stage for Gene Therapy's Future
MIT Technology Review
by Emily Mullin; October 12, 2017; Allison Corona, 25, of Long Island, received a gene therapy five years ago that restored some of her vision. 1. Up until five years ago, Allison Corona's life was shrouded in darkness. Born with an inherited eye ...
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal ...The Lancetall 134 news articles »
Read more »